| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 03/09/2011 | EP2291354A1 Compound comprising phenyl pyridine units |
| 03/09/2011 | EP2291080A1 Novel modulators of sphingosine phosphate receptors |
| 03/09/2011 | EP2291077A1 Process for the preparation of rho-kinase inhibitor compounds |
| 03/09/2011 | EP1874770B1 Phenylacetamides suitable as protein kinase inhibitors |
| 03/09/2011 | EP1841735B1 Indoles useful in the treatment of inflammation |
| 03/09/2011 | EP1723136B1 Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 03/09/2011 | EP1692116B1 1,2,3-triazole amide derivatives as inhibitors of cytokine production |
| 03/09/2011 | EP1622892B1 Indazoles having analgesic activity |
| 03/09/2011 | EP1620434B1 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 03/09/2011 | EP1569910B1 Pesticidal sulphonylaminopyrazoles |
| 03/09/2011 | EP1513812B1 Substituted indoles |
| 03/09/2011 | EP1497279B1 Substituted indoles and their use as 5ht-reuptake inhibitors and as 5ht ligands |
| 03/09/2011 | CN1582274B Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 03/09/2011 | CN101580501B Synthetic method of 3-(substituted dihydro-isoindolone-2-group)-2,6-dioxopiperidine and intermediate thereof |
| 03/08/2011 | US7902379 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 03/08/2011 | US7902370 Solid forms of the magnesium salt of S-omeprazole and processes for their preparation |
| 03/08/2011 | US7902369 Diaryl-substituted five-membered heterocycle derivative |
| 03/08/2011 | US7902367 Cyclic amino benzoic acid derivative |
| 03/08/2011 | US7902366 NK1 antagonists |
| 03/08/2011 | US7902358 Gastrointestinal disorders; inflammatory bowel disorders; gastroesophageal reflux, constipation; diarrhea |
| 03/08/2011 | US7902356 Thiazolopyridinone derivates as MCH receptor antagonists |
| 03/08/2011 | US7902241 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease |
| 03/08/2011 | US7902239 Diaminotriazoles useful as inhibitors of protein kinases |
| 03/08/2011 | US7902233 Compounds useful as pesticides |
| 03/08/2011 | US7902231 Anthropodicidal anthranilamides |
| 03/08/2011 | US7902230 Benzimidazole derivatives and their use for modulating the GABAA receptor complex |
| 03/08/2011 | US7902229 Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
| 03/08/2011 | US7902226 Dehalogeno-compounds |
| 03/08/2011 | US7902225 Mycobacterial inhibitors |
| 03/08/2011 | US7902223 Phenyl derivatives as factor XA inhibitors |
| 03/08/2011 | US7902217 Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 03/08/2011 | US7902200 Chemical compounds |
| 03/08/2011 | US7902199 Heterocyclic substituted piperazine compounds with CXCR3 antagonist activity |
| 03/08/2011 | US7902198 Crystalline aripiprazole solvates |
| 03/08/2011 | US7902184 Piperazinyl pyrimidine derivatives |
| 03/08/2011 | US7902181 Compounds 010 |
| 03/08/2011 | CA2689051C Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/08/2011 | CA2557791C Controlled-release pharmaceutical composition and method for producing the same |
| 03/08/2011 | CA2488202C 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 03/08/2011 | CA2468691C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists |
| 03/08/2011 | CA2464721C Nitrogenous (tetrahydropyridyl) (alkyl) heterocycles with tnf activity |
| 03/08/2011 | CA2457061C Tetrazoyloxime derivative and agricultural chemical containing the same as active ingredient |
| 03/08/2011 | CA2420899C Hydroxamate derivatives useful as deacetylase inhibitors |
| 03/08/2011 | CA2415396C 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications |
| 03/03/2011 | WO2011025927A1 Compounds and compositions as protein kinase inhibitors |
| 03/03/2011 | WO2011025541A1 Cannabinoid receptor modulators |
| 03/03/2011 | WO2011025006A1 Gpr119 agonist |
| 03/03/2011 | WO2011024986A1 Organic electroluminescence device |
| 03/03/2011 | WO2011024933A1 3-(biaryloxy) propionic acid derivative |
| 03/03/2011 | WO2011024869A1 Fused heterocyclic ring derivative and use thereof |
| 03/03/2011 | WO2011023989A1 Aromatase inhibitor |
| 03/03/2011 | WO2011023812A1 Microsomal prostaglandin e synthase-1 (mpges1) inhibitors |
| 03/03/2011 | WO2011023703A1 Heterocyclic-substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof |
| 03/03/2011 | WO2011023677A1 Tetra-substituted heteroaryl compounds and their use as mdm2 and/or mdm4 modulators |
| 03/03/2011 | WO2011023626A1 Pyrrolidine derivatives as nk3 receptor antagonists |
| 03/03/2011 | WO2011023585A1 Piperidine derivatives used as orexin antagonists |
| 03/03/2011 | WO2011023578A1 5-methyl-piperidine derivatives as orexin receptor antagonists for the treatment of sleep disorder |
| 03/03/2011 | WO2011023146A1 Imatinib mesylate polymorphs generated by crystallization in aqueous inorganic salt solutions |
| 03/03/2011 | WO2011023081A1 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors |
| 03/03/2011 | WO2011022928A1 Quinolines compounds, their preparation methods, pharmaceutical compositions containing the same and use thereof |
| 03/03/2011 | WO2011006794A8 3-oxo-2, 3-dihydro-1h-isoindole-4-carboxamides as parp inhibitors |
| 03/03/2011 | WO2010128528A9 Piperidine derivatives useful for treatment of diebetes |
| 03/03/2011 | WO2010118711A4 Novel helquats, their precursors and method of preparation thereof |
| 03/03/2011 | WO2008078200A3 Benzenesulfonamide derivatives as hiv protease inhibitors |
| 03/03/2011 | WO2008035209A3 Quinoline and quinazoline derivatives as inhibitors of protein tyrosine kinase activity |
| 03/03/2011 | US20110054181 Near infrared fluorescent imaging agent |
| 03/03/2011 | US20110054180 Magnetic Nanoparticle-Supported Glutathione as a Sustainable Organocatalyst |
| 03/03/2011 | US20110054172 Pyridylaminoacetic acid compound |
| 03/03/2011 | US20110053987 Pyridinium and thiazolium conjugates including polyethylene glycols and methods of using the same |
| 03/03/2011 | US20110053983 (5r)-1,5-diaryl-4,5-dihydro-1h-pyrazole-3-carboxamidine derivatives having cb1-antagonistic activity |
| 03/03/2011 | US20110053980 Indane-amine derivatives, their preparation and use as medicaments |
| 03/03/2011 | US20110053979 Pyridine derivatives used to treat orexin related disorders |
| 03/03/2011 | US20110053975 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 03/03/2011 | US20110053968 Aminopyrimidine inhibitors of tyrosine kinase |
| 03/03/2011 | US20110053955 Anti-cytokine heterocyclic compounds |
| 03/03/2011 | US20110053954 Method of treatment and/or prevention of brain, spinal or nerve injury |
| 03/03/2011 | US20110053953 AZA-Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators - 613 |
| 03/03/2011 | US20110053952 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 03/03/2011 | US20110053950 4-benzylidene-3-methylpiperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053949 4-[3-(aryloxy)benzylidene]-3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors |
| 03/03/2011 | US20110053948 Pyrrolidines as nk3 receptor antagonists |
| 03/03/2011 | US20110053947 Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof |
| 03/03/2011 | US20110053946 Aryl-Quinolyl Compounds and Their Use |
| 03/03/2011 | US20110053943 CARBAMATE AND UREA INHIBITORS OF 11ß-HYDROXYSTEROID DEHYDROGENASE 1 |
| 03/03/2011 | US20110053941 IDO Inhibitors |
| 03/03/2011 | US20110053940 3,4-substituted piperidine derivatives as renin inhibitors |
| 03/03/2011 | US20110053939 Novel aromatic nitro compounds |
| 03/03/2011 | US20110053937 Inhibitors of the Interaction Between MDM2 and P53 |
| 03/03/2011 | US20110053935 Fused pyridines active as inhibitors of c-met |
| 03/03/2011 | US20110053934 Compounds and methods of treatment |
| 03/03/2011 | US20110053933 Hydroxyquinoxalinecarboxamide derivative |
| 03/03/2011 | US20110053931 Quinoline compounds and methods of use |
| 03/03/2011 | US20110053925 Hydroxamate-Based Inhibitors of Deacetylases |
| 03/03/2011 | US20110053918 Gamma secretase modulators |
| 03/03/2011 | US20110053915 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM |
| 03/03/2011 | US20110053907 Substituted pyrimidines and triazines and their use in cancer therapy |
| 03/03/2011 | US20110053905 Compounds as tyrosine kinase modulators |
| 03/03/2011 | US20110053891 5-fluoropyrimidinone derivatives |
| 03/03/2011 | US20110053770 Substituted aminothiazoles and their use as fungicides |
| 03/03/2011 | US20110053180 Kinase sensors |